Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway

Epalrestat is a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy. This study assumed that epalrestat had a protective effect on diabetic peripheral nerve injury by suppressing the expression of aldose reductase in peripheral nerves of diabetes me...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qing-rong, Wang, Zhuo, Zhou, Wei, Fan, Shou-rui, Ma, Run, Xue, Li, Yang, Lu, Li, Ya-shan, Tan, Hong-li, Shao, Qing-hua, Yang, Hong-ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811002/
https://www.ncbi.nlm.nih.gov/pubmed/27073391
http://dx.doi.org/10.4103/1673-5374.177745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811002/
https://www.ncbi.nlm.nih.gov/pubmed/27073391
http://dx.doi.org/10.4103/1673-5374.177745

Ejemplares similares